These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27895483)

  • 41. Activation of invariant Natural Killer T lymphocytes in response to the α-galactosylceramide analogue KRN7000 encapsulated in PLGA-based nanoparticles and microparticles.
    Macho Fernandez E; Chang J; Fontaine J; Bialecki E; Rodriguez F; Werkmeister E; Krieger V; Ehret C; Heurtault B; Fournel S; Frisch B; Betbeder D; Faveeuw C; Trottein F
    Int J Pharm; 2012 Feb; 423(1):45-54. PubMed ID: 21575695
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of PLGA nanoparticle loaded dissolving microneedles and comparison with hollow microneedles in intradermal vaccine delivery.
    Mönkäre J; Pontier M; van Kampen EEM; Du G; Leone M; Romeijn S; Nejadnik MR; O'Mahony C; Slütter B; Jiskoot W; Bouwstra JA
    Eur J Pharm Biopharm; 2018 Aug; 129():111-121. PubMed ID: 29803720
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dendritic cells support a proliferative antigen-specific T-cell response in the presence of poly(lactic-co-glycolic acid).
    Srinivasan S; Elizabeth Babensee J
    J Biomed Mater Res A; 2021 Nov; 109(11):2269-2279. PubMed ID: 33960123
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatitis B Antigen Loaded Biodegradable Polymeric Nanoparticles: Formulation Optimization and In-vivo Immunization in BALB/c Mice.
    Dewangan HK; Singh S; Maurya L; Srivastava A
    Curr Drug Deliv; 2018; 15(8):1204-1215. PubMed ID: 29866006
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumor growth inhibition by mSTEAP peptide nanovaccine inducing augmented CD8
    Chen Q; Bao Y; Burner D; Kaushal S; Zhang Y; Mendoza T; Bouvet M; Ozkan C; Minev B; Ma W
    Drug Deliv Transl Res; 2019 Dec; 9(6):1095-1105. PubMed ID: 31228097
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles.
    Maloy KJ; Donachie AM; O'Hagan DT; Mowat AM
    Immunology; 1994 Apr; 81(4):661-7. PubMed ID: 7518802
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A nanovaccine formulation of Chlamydia recombinant MOMP encapsulated in PLGA 85:15 nanoparticles augments CD4
    Sahu R; Dixit S; Verma R; Duncan SA; Coats MT; Giambartolomei GH; Singh SR; Dennis VA
    Nanomedicine; 2020 Oct; 29():102257. PubMed ID: 32610072
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hybrid nanovaccine for the co-delivery of the mRNA antigen and adjuvant.
    Yang J; Arya S; Lung P; Lin Q; Huang J; Li Q
    Nanoscale; 2019 Nov; 11(45):21782-21789. PubMed ID: 31709434
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8(+) T cell response: a comparative study.
    Cruz LJ; Rosalia RA; Kleinovink JW; Rueda F; Löwik CW; Ossendorp F
    J Control Release; 2014 Oct; 192():209-18. PubMed ID: 25068703
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recruitment of bone marrow CD11b
    Yang YW; Luo WH
    Sci Rep; 2017 Mar; 7():44691. PubMed ID: 28317931
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Highly enhanced cancer immunotherapy by combining nanovaccine with hyaluronidase.
    Guan X; Chen J; Hu Y; Lin L; Sun P; Tian H; Chen X
    Biomaterials; 2018 Jul; 171():198-206. PubMed ID: 29698869
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Probiotic-derived amphiphilic exopolysaccharide self-assembling adjuvant delivery platform for enhancing immune responses.
    Sheng S; Zhang H; Li X; Chen J; Wang P; Liang Y; Li C; Li H; Pan N; Bao X; Liu M; Zhao L; Li X; Guan P; Wang X
    J Nanobiotechnology; 2024 May; 22(1):267. PubMed ID: 38764014
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines.
    Patel GB; Zhou H; Ponce A; Chen W
    Vaccine; 2007 Dec; 25(51):8622-36. PubMed ID: 17959279
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immune responses to vaccines involving a combined antigen-nanoparticle mixture and nanoparticle-encapsulated antigen formulation.
    Zhang W; Wang L; Liu Y; Chen X; Liu Q; Jia J; Yang T; Qiu S; Ma G
    Biomaterials; 2014 Jul; 35(23):6086-97. PubMed ID: 24780166
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Polymer nanoparticles for enhanced immune response: combined delivery of tumor antigen and small interference RNA for immunosuppressive gene to dendritic cells.
    Heo MB; Cho MY; Lim YT
    Acta Biomater; 2014 May; 10(5):2169-76. PubMed ID: 24394635
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Near-infrared labeled, ovalbumin loaded polymeric nanoparticles based on a hydrophilic polyester as model vaccine: In vivo tracking and evaluation of antigen-specific CD8(+) T cell immune response.
    Rahimian S; Kleinovink JW; Fransen MF; Mezzanotte L; Gold H; Wisse P; Overkleeft H; Amidi M; Jiskoot W; Löwik CW; Ossendorp F; Hennink WE
    Biomaterials; 2015 Jan; 37():469-77. PubMed ID: 25453974
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro.
    Sun H; Pollock KG; Brewer JM
    Vaccine; 2003 Feb; 21(9-10):849-55. PubMed ID: 12547593
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Controlled release of antigen and Toll-like receptor ligands from PLGA nanoparticles enhances immunogenicity.
    Cruz LJ; Tacken PJ; Eich C; Rueda F; Torensma R; Figdor CG
    Nanomedicine (Lond); 2017 Mar; 12(5):491-510. PubMed ID: 28181470
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhanced stimulation of anti-breast cancer T cells responses by dendritic cells loaded with poly lactic-co-glycolic acid (PLGA) nanoparticle encapsulated tumor antigens.
    Iranpour S; Nejati V; Delirezh N; Biparva P; Shirian S
    J Exp Clin Cancer Res; 2016 Oct; 35(1):168. PubMed ID: 27782834
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biodegradable nanoparticles containing TLR3 or TLR9 agonists together with antigen enhance MHC-restricted presentation of the antigen.
    Lee YR; Lee YH; Im SA; Yang IH; Ahn GW; Kim K; Lee CK
    Arch Pharm Res; 2010 Nov; 33(11):1859-66. PubMed ID: 21116790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.